{
  "trial_id": "NCT02577003",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), duration of Type 2 diabetes mellitus, baseline HbA1c, fasting plasma glucose, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function (serum creatinine, estimated glomerular filtration rate), liver function tests (ALT, AST), concomitant medications, history of cardiovascular disease, smoking status, alcohol consumption.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "HbA1c",
          "baseline HbA1c"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "renal function (serum creatinine, estimated glomerular filtration rate)"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "fasting plasma glucose"
        ],
        [
          "Body Weight",
          "body mass index (BMI)"
        ],
        [
          "Prior use of other antihyperglycemic agents (AHAs)",
          "concomitant medications"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "2-hour Post-Meal Glucose (2-hr PMG)",
        "Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal"
      ],
      "remaining_candidate_features": [
        "duration of Type 2 diabetes mellitus",
        "blood pressure",
        "lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides)",
        "liver function tests (ALT, AST)",
        "history of cardiovascular disease",
        "smoking status",
        "alcohol consumption"
      ]
    },
    "processed-gen-response": "Age, gender, body mass index (BMI), duration of Type 2 diabetes mellitus, baseline HbA1c, fasting plasma glucose, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function (serum creatinine, estimated glomerular filtration rate), liver function tests (ALT, AST), concomitant medications, history of cardiovascular disease, smoking status, alcohol consumption."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Antidiabetic Medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "HbA1c",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Body Weight",
          "Body Mass Index"
        ],
        [
          "Prior use of other antihyperglycemic agents (AHAs)",
          "Use of Antidiabetic Medications"
        ]
      ],
      "remaining_reference_features": [
        "Estimated Glomerular Filtration Rate (eGFR)",
        "2-hour Post-Meal Glucose (2-hr PMG)",
        "Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Antidiabetic Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Fasting Plasma Glucose, Total Cholesterol, Triglycerides, HDL-C, LDL-C, eGFR, Urinary Albumin-to-Creatinine Ratio.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "eGFR"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Body Weight",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "2-hour Post-Meal Glucose (2-hr PMG)",
        "Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal",
        "Prior use of other antihyperglycemic agents (AHAs)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "HDL-C",
        "LDL-C",
        "Urinary Albumin-to-Creatinine Ratio"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Fasting Plasma Glucose, Total Cholesterol, Triglycerides, HDL-C, LDL-C, eGFR, Urinary Albumin-to-Creatinine Ratio."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, HbA1c at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, history of hypertension, history of dyslipidemia, history of cardiovascular disease, smoking status, estimated glomerular filtration rate (eGFR) at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "HbA1c",
          "HbA1c at baseline"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "estimated glomerular filtration rate (eGFR) at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Fasting Plasma Glucose (FPG)",
        "2-hour Post-Meal Glucose (2-hr PMG)",
        "Glucose Total Area Under the Plasma Concentration Curve from Hour 0 to Hour 2 (AUC0-2hr) after Meal",
        "Body Weight",
        "Prior use of other antihyperglycemic agents (AHAs)"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of type 2 diabetes mellitus",
        "fasting plasma glucose at baseline",
        "systolic blood pressure at baseline",
        "diastolic blood pressure at baseline",
        "history of hypertension",
        "history of dyslipidemia",
        "history of cardiovascular disease",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, HbA1c at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, history of hypertension, history of dyslipidemia, history of cardiovascular disease, smoking status, estimated glomerular filtration rate (eGFR) at baseline."
  }
}